New Sandwich-Type Enzyme-Linked Immunosorbent Assay for Human MxA Protein in a Whole Blood Using Monoclonal Antibodies Against GTP-Binding Domain for Recognition of Viral Infection

Journal of Clinical Laboratory Analysis

Volumn 26, Issue 3, 2012, Pages 174-183

  Kawamura, Mizuho ^a   Kusano, Akira ^b   Furuya, Akiko ^b   Hanai, Nobuo ^b   Tanigaki, Hideki ^a   Tomita, Akihito ^a   Horiguchi, Akira ^c   Nagata, Kyosuke ^d   Itazawa, Toshiko ^e   Adachi, Yuichi ^e   Okabe, Yoshie ^e   Miyawaki, Toshio ^e   Kohno, Hiroaki ^a  

^a Kyowa Medex Co Ltd   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

^c Kyowa Medex Co Ltd   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Bacterial infection; High stability; Interferon , high sensitivity; Rapid assay

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; HEMOGLOBIN; MONOCLONAL ANTIBODY; MYXOVIRUS RESISTANCE PROTEIN A;

ANIMAL CELL; ARTICLE; BLOOD; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; LIMIT OF DETECTION; MALE; MOUSE; NONHUMAN; PRESCHOOL CHILD; PROTEIN ANALYSIS; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; VIRUS INFECTION;

ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL INFECTIONS; BINDING SITES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GTP-BINDING PROTEINS; HUMANS; INFANT; MALE; MICE; PROTEIN STABILITY; SENSITIVITY AND SPECIFICITY; VIRUS DISEASES;

BACTERIA (MICROORGANISMS);

EID: 84861474006     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21507     Document Type: Article

References (30)

1. Taylor JL, Grossberg SE. Recent progress on interferon research: Molecular mechanisms of regulation, action, and virus circumvention. Virus Res 1990;15:1-26.
2. Belardelli F. Role of interferon and other cytokines in the regulation of the immune response. APMIS 1995;103:161-179.
3. Kuzrrock R, Rosenblum MG, Sherwin AA, et al. Pharmacokinetics, single-dose tolerance, and biological activity of recombinant interferon-gamma in cancer patients. Cancer Res 1985;45:2866-2872.
4. Oh S-K, Luhowskyj S, Witt P, et al. Quantitation of interferon-induced Mx protein in whole blood lysates by an immunochemiluminescent assay: Elimination of protease activity of cell lysates in toto. J Immunol Methods 1994;176:79-91.
5. Sen CS, Lengyel P. A bird's eye view of its biochemistry. J Biol Chem 1992;267:5017-5020.
6. Chieux V, Hober D, Harvey J, et al. The MxA protein level in whole blood lysates of patients with various viral infections. J Virol Mehods 1998;70:183-191.
7. Horisberger MA. Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. Virology 1992;66:4705-4709.
8. von Wussow P, Jakschies D, Hochkeppel KH, Fibisch C, Penner L, Deicher H. The human intracellular Mx-homologous protein is specifically induced by type I interferons. Eur J Immunol 1990;20:2015-2019.
9. Towbin H, Schmitz A, Jackschies D, von Wussow P, Horisberger MA. A whole blood immunoassay for the interferon-inducible human Mx protein. J Interferon Res 1992;12:67-74.
10. Ronni T, Melen K, Malygin A, Julkunen I. Control of IFN-inducible MxA gene expression in human cells. J Immunol 1993;150:1715-1718.
11. Simon A, Fäh J, Haller O, Staeheli P. Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines. J Virol 1991;65:968-971.
12. Meier V, Mihm S, Ramadori G. MxA gene expression in peripheral blood mononuclear cells from patients infected chronically with hepatitis C virus treated with interferon-alpha. J Med Virol 2000;62:318-326.
13. Halminen M, Ilonen J, Julkunen I, Ruuskanen O, Simell O, Mäkelä MJ. Expression of MxA protein in blood lymphocytes discriminates between viral and bacterial infections in febrile children. Pediatr Res 1997;41:647-650.
14. Baca LM, Gems P, Kalvakolanu D, et al. Regulation of interferon-α-inducible cellular genes in human immunodeficiency virus-infected monocytes. J Leukocyte Biol 1994;55:299-309.
15. Jakschies D, Armbrust A, Clare KU, et al. Significant difference of the MxA-protein expression in human PBL of patients with viral and bacterial infections. J Interferon Res 1994;14:S124.
16. Haller O, Kochs G. Interferon-induced Mx proteins: Dynamin-like GTPases with antiviral activity. Traffic 2002;3:710-717.
17. Staeheli P, Haller O, Boll W, Lindenmann J, Weissmann C. Mx protein: Constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 1986;44:147-158.
18. Zhao H, De BP, Das T, Banerjee AK. Inhibition of human parainfluenza virus-3 replication by interferon and human MxA. Virology 1996;220:330-338.
19. Schnorr JJ, Schneider-Schaulies S, Simon-Jodicke A, Pavlovic J, Horisberger MA, ter Meulen V. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J Virol 1993;67:4760-4768.
20. Chieux V, Chehadeh W, Harvey J, Haller O, Wattre P, Hober D. Inhibition of coxsackievirus B4 replication in stably transfected cells expressing human MxA protein. Virology 2001;283:84-92.
21. Horisberger MA, McMaster G, Zeller H, Wathelet M, Dellis MG, Content J. Cloning and sequence analysis of cDNAs for interferon- and virus-induced human Mx-proteins reveal that they contain putative guanine nucleotide-binding site: Functional study of the corresponding gene promoter. J Virol 1990;64:1171-1181.
22. Kohno H, Sato S, Chiba H, et al. Monoclonal antibodies specific for 18-hydroxycortisol and their use in an enzyme immunoassay for human urinary 18-hydrocortisol for diagnosis of primary aldosteronism. Clin Biochem 1994;27:227-282.
23. Djavadi-Ohaniance L, Goldberg ME, Friguet B. Chapter 4. Measuring antibody affinity in solution. In: McCafferty J, editor. Antibody Engineering. Oxford: IRL Press; 1996. p 77-97.
24. Kohno H, Sueshige N, Oguri K, et al. Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using anti-oxidized phosphatidylcholine monoclonal antibody and anti-human apolipoprotein-B antibody. Clin Biochem 2000;33:243-253.
25. Bradford MM. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
26. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843.
27. Huang N, Morlock L, Lee CH, Chen LS, Chou YJ. Antibiotic prescribing for children with nasopharyngitis (common colds), upper respiratory infections, and bronchitis who have health-professional parents. Pediatrics 2005;116:826-832.
28. Baker MD, Bell LM, Avner JR. Outpatient management without antibiotics of fever in selected infants. N Eng1 J Med 1993;329:1437-1441.
29. Baskin MN, O'Rourke EJ, Fleisher OR. 1992. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr 120: 22-27.
30. Jaskiewicz JA, McCarthy CA, Richardson AC, et al. Febrile infants at low risk for serious bacterial infection-an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics 1994;94:390-396.